Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer()

Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with an overall median 5-year survival rate of 8%. This poor prognosis is because of the development of resistance to chemotherapy and radiation therapy and lack of effective targeted therapies. IκB kinase enhancer (IKBKE) overexpression wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Challa, Sridevi, Husain, Kazim, Kim, Richard, Coppola, Domenico, Batra, Surinder K., Cheng, Jin Q., Malafa, Mokenge P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994835/
https://www.ncbi.nlm.nih.gov/pubmed/32004866
http://dx.doi.org/10.1016/j.tranon.2019.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994835/
https://www.ncbi.nlm.nih.gov/pubmed/32004866
http://dx.doi.org/10.1016/j.tranon.2019.11.009

Ejemplares similares